8 active not recruiting. 8 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Active not recruiting 8 |
| Phase 1 | 3 | Active not recruiting 3 |
Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fructose for Acute Ischemic Stroke 10% Fructose Injection - Acute Ischemic Stroke | Phase 2 | Active not recruiting | Ji Xunming,MD,PhD | 46 | 2026-06-05 | 2026-06-18 |
| A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT LT3001 Drug Product, Placebo - Acute Ischemic Stroke | Phase 2 | Active not recruiting | Lumosa Therapeutics Co., Ltd. | 66 | 2022-08-11 | 2026-08-31 |
| Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial Tadalafil 20 MG, Placebo - Cerebral Small Vessel Diseases, Stroke, Ischemic | Phase 2 | Active not recruiting | Christina Kruuse | 100 | 2022-05-31 | 2024-12-09 |
| Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct Conditioned Medium, Umbilical Cord Mesenchymal Stem Cells, Neurologic and Neutrophic Drugs - Ischemic Stroke | Phase 1 / Phase 2 | Active not recruiting | PT. Prodia Stem Cell Indonesia | 15 | 2022-05-30 | 2026-02-25 |
| Trial of PCSK9 Inhibition in Patients with Acute Stroke and Symptomatic Intracranial Atherosclerosis Alirocumab - Intracranial Atherosclerosis, Acute Ischemic Stroke | Phase 2 | Active not recruiting | Chang Gung Memorial Hospital | 60 | 2021-08-01 | 2025-03-26 |
| Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke Spironolactone Pill - Intracerebral Hemorrhage, Ischemic Stroke | Phase 2 | Active not recruiting | Yale University | 160 | 2021-03-19 | 2026-09-04 |
| A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS) Neural Stem Cells - Ischemic Stroke | Phase 1 / Phase 2 | Active not recruiting | Clarion Cells, Inc. | 27 | 2021-01-04 | 2026-08-12 |
| A Study of NCS-01 in Patients With Acute Ischemic Stroke NCS-01 - Ischemic Stroke | Phase 1 / Phase 2 | Active not recruiting | NC Medial Research Inc | 16 | 2020-02-27 | 2025-09-11 |
Cerebral Hemorrhage (1) · Cerebral Small Vessel Diseases (1) · Intracranial Arteriosclerosis (1)
Brain Diseases (8) · Cardiovascular Diseases (8) · Central Nervous System Diseases (8) · Cerebrovascular Disorders (8) · Nervous System Diseases (8) · Stroke (8) · Vascular Diseases (8) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Hemorrhage (1) · Intracranial Arterial Diseases (1) · Intracranial Hemorrhages (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Culture Media, Conditioned (1) · Fructose (1) · Secretome (1) · Spironolactone (1) · Tadalafil (1) · alirocumab (1)
Chang Gung Memorial Hospital (1) · Christina Kruuse (1) · Clarion Cells, Inc. (1) · Ji Xunming,MD,PhD (1) · Lumosa Therapeutics Co., Ltd. (1) · NC Medial Research Inc (1) · PT. Prodia Stem Cell Indonesia (1) · Yale University (1)
United States (4) · Taiwan (2) · China (1) · Denmark (1) · Indonesia (1)
Christina Kruuse, MD, Prof (1) · Gary K Steinberg, MD, PhD (1) · Kevin Sheth, MD (1) · Rima Haifa (1) · Sean Savitz, md (1) · Yenchu Huang, MD (1)
PMID 35487727, PMID 39210472, PMID 40718899, PMID 41332889, PMID 42714476